No Data
No Data
No Data
No Data
No Data
Johnson & Johnson (NYSE:JNJ) Notches Up After Talc Win
TipRanks15:36 ET
Research Alert: CFRA Retains Hold View On Shares Of Johnson & Johnson
CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We cut our target to $156 from $165, 13.
MT Newswires12:50 ET
WHO Considering Safety Alert on Kenvue Kids Cough Syrup
Seeking Alpha12:49 ET
Brexit Impact On Drugs - Rising Shortages in UK Highlight Brexit Challenges
Drug shortages in the UK have more than doubled between 2020 and 2023, a recent study by the Nuffield Trust reveals. Brexit is cited as a significant factor exacerbating the country's struggle to mana
BenzingaApr 19 11:39 ET
Johnson & Johnson Children's Cough Syrup Contaminated In Some Batches - WHO Poised to Issue Global Alert
The World Health Organization (WHO) is poised to issue a broader alert regarding contaminated children's cough syrup produced by Johnson and Johnson (NYSE:JNJ) in response to the discovery of tainted
BenzingaApr 19 10:17 ET
FDA Mandates "Boxed Warning" For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therapies
Following an investigation announced in November last year, the FDA said on Thursday that it would now require boxed warnings—the highest safety-related caution for medications—for all chimeric antige
BenzingaApr 19 09:28 ET
No Data
No Data